What is HC Wainwright’s Estimate for RNAC Q1 Earnings?
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Cartesian Therapeutics in a report released on Monday, May 19th. HC Wainwright analyst M. Kapoor anticipates that the company will post earnings per share of ($0.80) for the quarter. HC Wainwright […]
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Cartesian Therapeutics in a report released on Monday, May 19th. HC Wainwright analyst M. Kapoor anticipates that the company will post earnings per share of ($0.80) for the quarter. HC Wainwright […]
